COMMUNIQUÉS West-GlobeNewswire

New REDUCE-IT® Analyses Presented at ESC 2025 Include Data Showing VASCEPA®/VAZKEPA® (Icosapent Ethyl) Therapy Resulted in 9% Fewer Total Hospitalizations & Reduces Cardiovascular Disease Risk in Certain High-Risk Patient Subgroups
30/08/2025
-- 2025 ESC/EAS Dyslipidemia Guideline Focused Update Reaffirms High Dose Icosapent Ethyl as Class IIA Recommended Therapy in High-Risk or Very High-Risk Patients Based on REDUCE-IT -- DUBLIN and BRIDGEWATER, N.J., Aug [...]
Roche and Alnylam advance zilebesiran into global phase III cardiovascular outcomes trial for people with uncontrolled hypertension
30/08/2025
Phase III trial informed by comprehensive KARDIA data set generated through three Phase II studies: KARDIA-1, KARDIA-2 and KARDIA-3 In the Phase II KARDIA-3 study, presented today as a late breaker at the European [...]
Novartis Leqvio® shows statistically significant and clinically meaningful early LDL-C goal achievement with less muscle pain
30/08/2025
V-DIFFERENCE is first study to show that Leqvio prioritized after statins helps more patients achieve guideline low-density lipoprotein cholesterol (LDL-C) goals early with reduced muscle pain 1 85% of patients on [...]
Acoramidis Demonstrates Statistically Significant Reduction in Cardiovascular Mortality (CVM) through Month 42 of the ATTRibute-CM Open Label Extension
30/08/2025
- Acoramidis demonstrated a significant reduction in risk of CVM through 42 months post-randomization, with a 44% hazard reduction, setting a new standard for CVM outcomes for patients with ATTR-CM - Acoramidis also [...]
Cytokinetics Announces Primary Results from MAPLE-HCM Presented at the European Society of Cardiology Congress 2025 and Published in The New England Journal Of Medicine
30/08/2025
Positive Trial Demonstrates Superiority of Aficamten to Standard-of-Care Beta-Blocker Metoprolol Primary Endpoint Result Consistent Across All Prespecified Subgroups Company to Host Investor Event and Webcast Tuesday [...]
Empower Dental Upland Announces Grand Opening, Bringing Advanced Dental Care and Compassionate Services to the Upland Community
29/08/2025
Upland, CA, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Empower Dental Upland has officially opened its doors, marking the newest addition to the Empower Dental Group which operates practices across California. The opening [...]
Informations sur le nombre total de droits de vote et d'actions
29/08/2025
INFORMATION RÉGLEMENTÉE Informations sur le nombre total de droits de vote et d'actions Mont-Saint-Guibert (Belgique), le 29 aout 2025, 22:30h CET / 16:30h ET – Conformément à l'article 15 de la loi du 2 mai 2007 [...]
Information on the total number of voting rights and shares
29/08/2025
REGULATED INFORMATION Information on the total number of voting rights and shares Mont-Saint-Guibert (Belgium), August 29, 2025 , 10:30 pm CET / 4:30 pm ET – In accordance with article 15 of the Law of 2 May 2007 on the [...]
Ultragenyx to Participate at Investor Conferences in September
29/08/2025
NOVATO, Calif., Aug. 29, 2025 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for serious rare and ultra [...]
Integra LifeSciences Leadership to Present at Wells Fargo and Morgan Stanley Healthcare Investor Conferences
29/08/2025
PRINCETON, N.J., Aug. 29, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today announced that chief executive officer Mojdeh Poul and [...]
Alliance Recovery Expands in Orange County, California, Improving Access to Affordable Addiction Treatment
29/08/2025
Expansion at Alliance Recovery in Orange County, CA increases treatment capacity by 16 and paves the way for a future Los Angeles detox facility. FOUNTAIN VALLEY, Calif., Aug. 29, 2025 (GLOBE NEWSWIRE) -- Alliance [...]
FDA Approves LEQEMBI® IQLIK™ (lecanemab-irmb) Subcutaneous Injection for Maintenance Dosing for the Treatment of Early Alzheimer's Disease
29/08/2025
LEQEMBI IQLIK is the first and only anti-amyloid treatment to offer an at-home injection to help patients and care partners continue to treat this progressive, relentless disease after initial treatment of 18 months [...]
Biomerica Reports Fiscal 2025 Year End Results
29/08/2025
$1.3 Million in Operating Expense Reductions Achieved– Operating Loss Improves 19% Year-Over-Year Resilient Portfolio Performance with International Sales Despite Global Economic Uncertainties Cash Used in Operating [...]
Communiqué de presse : Wayrilz de Sanofi est approuvé aux États-Unis comme premier inhibiteur de BTK pour la thrombocytopénie immune
29/08/2025
Wayrilz de Sanofi est approuvé aux États-Unis comme premier inhibiteur de BTK pour la thrombocytopénie immune Ce traitement novateur cible la tyrosine kinase de Bruton (BTK) par une modulation multi-immune pour aider à [...]
Press Release: Sanofi’s Wayrilz approved in US as first BTK inhibitor for immune thrombocytopenia
29/08/2025
Sanofi’s Wayrilz approved in US as first BTK inhibitor for immune thrombocytopenia Novel treatment targets BTK through multi-immune modulation to help address root causes of ITP Approval based on LUNA 3 phase 3 study [...]
Aja Health and Wellness Inc. Announces Agreement for the Purchase of Assets of Canadian Travel and Doctors Clinics Inc., Announces Share Subscription Agreement with GEM Global Yield LLC SCS, and Provides Update on Delay in Filing Financial Statements
30/08/2025
Not for dissemination in the United States of America VANCOUVER, British Columbia, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Aja Health and Wellness Inc. ("Aja" or the "Company") (TSXV:Aja) announces that its wholly-owned [...]
Outliyr Releases Biological Age Testing Case Study Revealing 13.1-Year Variation Across Seven Products
29/08/2025
Same-day comparison conducted by Outliyr founder Nick Urban shows major discrepancies between biological age results using epigenetic clocks, glycans, RNA multi-omics, and clinical biomarkers. Austin, TX, Aug. 29, 2025 [...]
KFSHRC Sets Global Benchmark in Robotic Surgery, Expanding World-First Innovations
29/08/2025
RIYADH, Saudi Arabia, Aug. 29, 2025 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSHRC) is redefining global standards in robotic surgery, building on unprecedented world-firsts including [...]
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
29/08/2025
VANCOUVER, British Columbia and BOSTON, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development, [...]

Pages